Asia Markets: Asian stocks mostly lower early Thursday amid declining confidence in U.S. economy and escalating political turmoil

Don’t miss:Trump says Kentucky attorney general is ‘handling’ Breonna Taylor situation ‘very well’ and refuses to commit to peaceful transition of power

Risks of a broader selloff of technology shares after a long due correction, Hayaki Narita at Mizuho Bank in Singapore said in a report.

“Add to that, the growing severity of ‘second wave’ risks in Europe, with the U.K. and France seeing a worrying escalation in new cases,” in addition to flare-ups in the U.S., Canada and elsewhere, he said.

Japan’s benchmark Nikkei 225 NIK, -1.21%  declined 0.7% to 23,185.16. Australia’s S&P/ASX 200 XJO, -1.08%  slipped nearly 1.0% to 5,866.90. South Korea’s Kospi 180721, -2.29%  plunged 1.9% to 2,288.28. Hong Kong’s Hang Seng HSI, -1.95%  dropped 1.4% to 23,408.88, while the Shanghai Composite SHCOMP, -1.36%  was down nearly 1.0% at 3,248.46.

“Weak leads from Wall Street continue to be the bane of Asia markets as regional indices broadly slipped,” said Jingyi Pan, market strategist at IG.

Wall Street experienced more whiplash Wednesday as stocks closed broadly lower, wiping out gains from the day before. The S&P 500 SPX, -2.37%  fell 2.4% to 3,236.92, erasing an earlier gain. The widespread selling accelerated in the afternoon, though technology stocks accounted for the biggest losses. The decline deepens the benchmark index’s September slide to 7.5% after a five-month rally.

The Dow Jones Industrial Average DJIA, -1.92%  lost 1.9% to 26,763.13. The Nasdaq COMP, -3.01%  slid 3% to 10,632.99 and the Russell 2000 RUT, -3.04%  index of small-company stocks gave up 3% to 1,451.46.

Apart from worries over the pandemic and politics, Big Tech stocks like Apple AAPL, -4.19%  and Amazon AMZN, -4.12%  have been at the center of the market’s big swings. They soared on expectations that their growth will only strengthen as the pandemic accelerates work-from-home and other trends favoring digitization. But they began falling early this month amid fears that they had grown too expensive.

Johnson & Johnson JNJ, +0.15%  rose 0.2% as it began a huge final study to try to prove if a single dose COVID-19 vaccine can protect against the coronavirus. A handful of other vaccines are already in final-stage studies, and investors increasingly expect one to be available within the first three months of 2021. The hope is that it can help revive the economy and spur strong growth.

Part of this week’s early stumble for stocks was due to worries about European governments imposing tougher restrictions on businesses to slow the spread of the coronavirus, which hurt travel-related companies in particular.

In energy trading, benchmark U.S. crude CL.1, -1.02%   fell 42 cents to $39.51 a barrel in electronic trading on the New York Mercantile Exchange. Brent crude BRN00, -0.78%, the international standard, lost 34 cents to $41.43 a barrel.

The U.S. dollar cost inched up to 105.44 Japanese yen USDJPY, +0.03%  from 105.38 yen late Wednesday. The euro EURUSD, -0.03%  was trading at $1.1661, almost unchanged from $1.1660.